title: Antihistamines in chronic urticaria: threat or treat?
authors.forename: Omür
authors.initials: O
authors.lastname: Aydin
authors.forename: Gülfem
authors.initials: G
authors.lastname: Celik
authors.forename: Zeynep
authors.initials: Z
authors.lastname: Misirligil
mesh_terms: D000284:Administration, Oral; D000328:Adult; D017332:Cetirizine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D002908:Chronic Disease; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D005260:Female; D006633:Histamine Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D017336:Loratadine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D008297:Male; D010632:Pheniramine / Q000008:administration & dosage / Q000009:adverse effects; D011237:Predictive Value of Tests; D012882:Skin Tests; D014581:Urticaria
chemical_list: D006633:Histamine Antagonists; D010632:Pheniramine; D017336:Loratadine; D017332:Cetirizine